Pleiades is a family of whole-genome epigenetic foundation models spanning 90M, 600M, and 7B parameters. The first of our biological foundation models, Pleiades sets new benchmarks for understanding genetic and epigenetic patterns of human cells in health and disease. Applied to the study of Alzheimer's and Parkinson's diseases, Pleiades is able to innately discover signatures of early disease with high accuracy, read more here.
In development.
SANDBOX is a landmark research study launching across 15 NHS sites in the UK, aiming to recruit over 1,000 patients. It combines innovative blood biomarkers and genotyping with remote cognitive testing to enable earlier, more accurate detection of cognitive decline. By building a scalable platform for early screening and care pathway innovation, SANDBOX is laying the clinical foundation for precision neuroscience: data-rich, AI-enabled, and designed to improve real-world outcomes.
READOUT is the UK's leading dementia diagnostics study, led by the University of Oxford and supported by the NIHR. As an industry partner, Prima Mente is generating rich, longitudinal clinical and -omics data to model disease risk, progression, and underlying biology across the dementia spectrum.